PH31258A - New use of ropivacaine. - Google Patents

New use of ropivacaine.

Info

Publication number
PH31258A
PH31258A PH48413A PH48413A PH31258A PH 31258 A PH31258 A PH 31258A PH 48413 A PH48413 A PH 48413A PH 48413 A PH48413 A PH 48413A PH 31258 A PH31258 A PH 31258A
Authority
PH
Philippines
Prior art keywords
pct
ropivacaine
new use
sec
date
Prior art date
Application number
PH48413A
Other languages
English (en)
Inventor
Eek Arne Toraka
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH31258(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH31258A publication Critical patent/PH31258A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electromechanical Clocks (AREA)
  • Air Conditioning Control Device (AREA)
  • Particle Accelerators (AREA)
  • Steroid Compounds (AREA)
PH48413A 1993-06-28 1994-06-09 New use of ropivacaine. PH31258A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
PH31258A true PH31258A (en) 1998-06-18

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48413A PH31258A (en) 1993-06-28 1994-06-09 New use of ropivacaine.

Country Status (32)

Country Link
US (2) US5670524A (cs)
EP (1) EP0706395B1 (cs)
JP (1) JP3725541B2 (cs)
CN (1) CN1074918C (cs)
AT (1) ATE216237T1 (cs)
BR (1) BR9406865A (cs)
CA (1) CA2165446C (cs)
CZ (1) CZ283300B6 (cs)
DE (2) DE706395T1 (cs)
DK (1) DK0706395T3 (cs)
EE (1) EE03205B1 (cs)
ES (1) ES2099048T3 (cs)
FI (1) FI956269A7 (cs)
GR (1) GR970300013T1 (cs)
HU (1) HU218949B (cs)
IL (1) IL110006A (cs)
IS (1) IS4174A (cs)
LT (1) LT3449B (cs)
LV (1) LV12918B (cs)
MY (1) MY119360A (cs)
NO (1) NO955313D0 (cs)
NZ (1) NZ268110A (cs)
PH (1) PH31258A (cs)
PL (1) PL175518B1 (cs)
PT (1) PT706395E (cs)
RU (1) RU2152215C1 (cs)
SA (1) SA94150010B1 (cs)
SE (1) SE9302218D0 (cs)
SG (1) SG49078A1 (cs)
SK (1) SK280111B6 (cs)
TW (1) TW285640B (cs)
WO (1) WO1995000148A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
EP2209450A4 (en) * 2007-11-07 2013-09-25 Svip5 Llc SLOW RELEASE OF LOCAL ANESTHESIC ORGANIC SALTS FOR PAIN RELIEF
EP2882745A2 (en) * 2012-05-10 2015-06-17 Cellixbio Private Limited Compositions and methods for the treatment of local pain
EP2846772A4 (en) * 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A HYDROPHOBIC ACTIVE SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF
KR102232806B1 (ko) 2013-02-28 2021-03-29 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000599A1 (en) * 1983-08-01 1985-02-14 A/S Apothekernes Laboratorium For Specialpraeparat L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
ES2099048T1 (es) 1997-05-16
SK164695A3 (en) 1996-07-03
GR970300013T1 (en) 1997-05-31
NO955313L (no) 1995-12-27
CA2165446C (en) 2005-07-05
LT3449B (en) 1995-10-25
US5834489A (en) 1998-11-10
SA94150010B1 (ar) 2006-04-04
JP3725541B2 (ja) 2005-12-14
DK0706395T3 (da) 2002-07-22
DE706395T1 (de) 1997-09-04
DE69430427D1 (de) 2002-05-23
ATE216237T1 (de) 2002-05-15
SE9302218D0 (sv) 1993-06-28
FI956269L (fi) 1995-12-27
US5670524A (en) 1997-09-23
CZ283300B6 (cs) 1998-02-18
AU692161B2 (en) 1998-06-04
LV12918B (en) 2003-03-20
MY119360A (en) 2005-05-31
FI956269A0 (fi) 1995-12-27
AU7086694A (en) 1995-01-17
TW285640B (cs) 1996-09-11
IL110006A0 (en) 1994-11-11
NO955313D0 (no) 1995-12-27
HUT75115A (en) 1997-04-28
ES2099048T3 (es) 2002-11-16
HU9503692D0 (en) 1996-02-28
EE03205B1 (et) 1999-08-16
HU218949B (hu) 2001-01-29
FI956269A7 (fi) 1995-12-27
NZ268110A (en) 1999-06-29
WO1995000148A1 (en) 1995-01-05
PT706395E (pt) 2002-09-30
PL312198A1 (en) 1996-04-01
PL175518B1 (pl) 1999-01-29
EP0706395B1 (en) 2002-04-17
JPH09500620A (ja) 1997-01-21
CZ336495A3 (en) 1996-06-12
EP0706395A1 (en) 1996-04-17
DE69430427T2 (de) 2002-11-14
SG49078A1 (en) 1998-05-18
BR9406865A (pt) 1996-03-26
CA2165446A1 (en) 1995-01-05
CN1126435A (zh) 1996-07-10
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
IS4174A (is) 1994-12-29
LTIP1958A (en) 1995-01-31
IL110006A (en) 1999-01-26
RU2152215C1 (ru) 2000-07-10
CN1074918C (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
IL113631A0 (en) New antagonist compounds
HU9503874D0 (en) New pharmaceutical formulation
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
AU2534295A (en) Gastrin and cck antagonists
TW285640B (cs)
CA2235747A1 (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
AU6053496A (en) The use of sertraline to treat post myocardial infarction patients
ZA965749B (en) Use of allylamines.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
SE9404438D0 (sv) New process
PL309593A1 (en) Application of rilusole as a radiorestaurantor